Hong Kong Stock Movement | ZHAOKE OPHTH-B (06622) Surges Over 7% Again as Company Forms Strategic Partnership with PT Ferron to Advance Core Product Commercialization in Indonesia

Stock News

Aug 15

ZHAOKE OPHTH-B (06622) continued its upward momentum with gains exceeding 7%. As of press time, the stock was up 6.48% to HK$4.27, with trading volume reaching HK$10.876 million.

On the news front, ZHAOKE OPHTH-B announced that the company has entered into a distribution and supply agreement with leading Indonesian pharmaceutical company PT Ferron Par Pharmaceuticals for the Indonesian market. The agreement covers the company's core product - atropine sulfate eye drops (NVK002), which is used to slow myopia progression in children and adolescents.

Under the terms of the agreement, ZHAOKE OPHTH-B has granted PT Ferron exclusive rights to import, promote, distribute, market and sell the product in Indonesia. ZHAOKE OPHTH-B will receive an upfront payment and is eligible for additional milestone payments based on certain achievements.

Additionally, earlier this year, ZHAOKE OPHTH-B's abbreviated new drug application for the 0.01% dose of atropine sulfate eye drops and new drug application for the 0.02% dose have been successively accepted by China's National Medical Products Administration and are currently under review.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1193204664"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1193204664\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1193204664?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 14:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193204664","market":"nz","top_or_hot":-1,"title":"Hong Kong Stock Movement | ZHAOKE OPHTH-B (06622) Surges Over 7% Again as Company Forms Strategic Partnership with PT Ferron to Advance Core Product Commercialization in Indonesia","media":"Stock News","content":"<p>ZHAOKE OPHTH-B (06622) continued its upward momentum with gains exceeding 7%. As of press time, the stock was up 6.48% to HK$4.27, with trading volume reaching HK$10.876 million.</p>\n<p>On the news front, ZHAOKE OPHTH-B announced that the company has entered into a distribution and supply agreement with leading Indonesian pharmaceutical company PT Ferron Par Pharmaceuticals for the Indonesian market. The agreement covers the company's core product - atropine sulfate eye drops (NVK002), which is used to slow myopia progression in children and adolescents.</p>\n<p>Under the terms of the agreement, ZHAOKE OPHTH-B has granted PT Ferron exclusive rights to import, promote, distribute, market and sell the product in Indonesia. ZHAOKE OPHTH-B will receive an upfront payment and is eligible for additional milestone payments based on certain achievements.</p>\n<p>Additionally, earlier this year, ZHAOKE OPHTH-B's abbreviated new drug application for the 0.01% dose of atropine sulfate eye drops and new drug application for the 0.02% dose have been successively accepted by China's National Medical Products Administration and are currently under review.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Movement | ZHAOKE OPHTH-B (06622) Surges Over 7% Again as Company Forms Strategic Partnership with PT Ferron to Advance Core Product Commercialization in Indonesia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Movement | ZHAOKE OPHTH-B (06622) Surges Over 7% Again as Company Forms Strategic Partnership with PT Ferron to Advance Core Product Commercialization in Indonesia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-15 14:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ZHAOKE OPHTH-B (06622) continued its upward momentum with gains exceeding 7%. As of press time, the stock was up 6.48% to HK$4.27, with trading volume reaching HK$10.876 million.</p>\n<p>On the news front, ZHAOKE OPHTH-B announced that the company has entered into a distribution and supply agreement with leading Indonesian pharmaceutical company PT Ferron Par Pharmaceuticals for the Indonesian market. The agreement covers the company's core product - atropine sulfate eye drops (NVK002), which is used to slow myopia progression in children and adolescents.</p>\n<p>Under the terms of the agreement, ZHAOKE OPHTH-B has granted PT Ferron exclusive rights to import, promote, distribute, market and sell the product in Indonesia. ZHAOKE OPHTH-B will receive an upfront payment and is eligible for additional milestone payments based on certain achievements.</p>\n<p>Additionally, earlier this year, ZHAOKE OPHTH-B's abbreviated new drug application for the 0.01% dose of atropine sulfate eye drops and new drug application for the 0.02% dose have been successively accepted by China's National Medical Products Administration and are currently under review.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1193204664","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193204664","pubTimestamp":1755239781,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ZHAOKE OPHTH-B (06622) continued its upward momentum with gains exceeding 7%. As of press time, the stock was up 6.48% to HK$4.27, with trading volume reaching HK$10.876 million. On the news front,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK4166":"消费信贷","BK1191":"制药","BK1587":"次新股","BK1574":"生物医药B类股","06622":"兆科眼科-B","PT":"品钛"},"translate_title":"港股动向|兆科OPHTH-B(06622)再涨超7%公司与PT Ferron建立战略合作伙伴关系推进印尼核心产品商业化","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06622":1,"PT":1},"content_text":"ZHAOKE OPHTH-B (06622) continued its upward momentum with gains exceeding 7%. As of press time, the stock was up 6.48% to HK$4.27, with trading volume reaching HK$10.876 million.\nOn the news front, ZHAOKE OPHTH-B announced that the company has entered into a distribution and supply agreement with leading Indonesian pharmaceutical company PT Ferron Par Pharmaceuticals for the Indonesian market. The agreement covers the company's core product - atropine sulfate eye drops (NVK002), which is used to slow myopia progression in children and adolescents.\nUnder the terms of the agreement, ZHAOKE OPHTH-B has granted PT Ferron exclusive rights to import, promote, distribute, market and sell the product in Indonesia. ZHAOKE OPHTH-B will receive an upfront payment and is eligible for additional milestone payments based on certain achievements.\nAdditionally, earlier this year, ZHAOKE OPHTH-B's abbreviated new drug application for the 0.01% dose of atropine sulfate eye drops and new drug application for the 0.02% dose have been successively accepted by China's National Medical Products Administration and are currently under review.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}